보고서 요약(국문)

시장 개요
전 세계 지속적 말초신경 차단 카테터 시장 규모는 2021년 XX백만 달러였으며, 2029년까지 XX백만 달러에 이를 것으로 예상됩니다. 예측 기간(2022-2029년) 동안 연평균 성장률(CAGR)은 XX%입니다.
지속적 말초신경 차단 카테터는 말초신경 근처에 삽입하여 마취제 또는 진통제를 신경에 직접 전달하는 작은 관입니다. 이 카테터를 사용하면 한 번의 주사가 아닌 장기간에 걸쳐 지속적으로 약물을 투여할 수 있습니다. 일반적으로 사지 또는 기타 말초 신체 부위 수술을 받은 환자의 수술 후 통증 관리에 사용됩니다.
시장 동향
기술 발전은 전 세계 지속적 말초신경 차단 카테터 시장 성장을 견인하고 있습니다. 지속적 말초신경 차단 카테터는 특히 병원에서 더욱 널리 사용되고 있는데, 이는 카테터 삽입이 더욱 정밀하게 이루어지고 다른 진통제 투여 기술보다 비용이 저렴하기 때문입니다.

지속적 말초신경 차단 카테터의 이점이 증가함에 따라 시장 성장이 촉진되고 있습니다.
발목 수술은 종종 수술 후 오피오이드 사용과 관련이 있으며, 이는 여러 수술 후 합병증과 연관되어 있는 것으로 알려져 있습니다. 2021년 Case Reports in Anesthesiology에 발표된 논문에 따르면, 지속적 말초신경 차단(CPNB)은 외래 발목 수술 환자의 통증 관리에 안전하고 효과적인 방법입니다. 또한 CPNB는 단회 말초신경 차단(PNB)에 비해 외래 정형외과 수술 후 추가 오피오이드 사용 필요성을 줄여주는 것으로 나타났습니다. 초기 연구에서는 감염 위험 증가로 인해 지속적 말초신경 차단 카테터는 48시간 후에 제거해야 한다고 제안했습니다.

CPNB는 수술 후 단회 PNB에 비해 차단의 지속 시간과 강도를 더욱 유연하게 조절할 수 있습니다. 초기 연구에 따르면 유치 말초신경 차단 카테터의 경우 48시간이 지나면 감염 위험이 증가하는 것으로 나타났습니다. 최근 연구에 따르면 말초 신경 카테터의 감염 없는 유지 확률은 4일째 99%에서 7일째 96%, 15일째 73%로 감소하는 것으로 보고되었습니다.
수술 종류에 따라 말초 신경 카테터는 완전한 진통 효과를 제공하여 회복 기간 동안 추가적인 진통제 투여의 필요성을 없앨 수 있습니다. 이는 환자 만족도 향상, 오피오이드 사용량 감소, 입원 기간 단축, 수술 후 지속적인 통증 감소로 이어질 수 있습니다. 또한 조기 운동, 관절 가동 범위 확대, 물리 치료 참여도 향상 등 기능 재활에도 도움이 될 수 있습니다.
그러나 지속적인 말초 신경 차단 카테터 사용과 관련된 위험 요소는 시장 성장을 저해할 수 있습니다.
지속적인 말초 신경 차단 카테터 사용에는 몇 가지 잠재적 위험이 있습니다. 모든 침습적 시술에는 감염 위험이 따릅니다. 위험도는 낮지만, 카테터 삽입 부위나 마취제 또는 진통제 투여 부위에서 감염이 발생할 수 있습니다. 카테터는 주변 신경을 손상시켜 해당 부위에 통증, 마비 또는 근력 약화를 유발할 수 있습니다. 카테터 삽입 부위에 혈전이 형성될 수 있으며, 혈전이 폐로 이동할 경우 생명을 위협할 수 있습니다. 모든 진통제는 과다 복용의 위험이 있으며, 카테터를 통한 지속적인 약물 투여는 이러한 위험을 증가시킵니다. 일부 환자는 카테터를 통해 투여되는 약물에 알레르기 반응을 보일 수 있습니다. 카테터가 이탈될 경우 통증, 출혈 또는 마취제나 진통제의 효과 감소를 초래할 수 있습니다.
COVID-19 영향 분석
COVID-19 팬데믹은 지속적 말초 신경 차단 카테터 시장에 특히 큰 영향을 미쳤습니다. 팬데믹으로 인해 이러한 카테터 시장의 상당 부분을 차지하는 선택적 수술이 연기되거나 취소되었습니다. 이로 인해 카테터 수요가 감소했습니다. 2021년 캐나다 마취학회지(The Canadian Journal of Anesthesia)에 게재된 논문에 따르면, SARS-CoV-2 바이러스로 인한 COVID-19 팬데믹은 사회와 의료 시스템에 큰 어려움을 초래했습니다. 팬데믹 초기 대응으로 인해 많은 선택적 수술과 비응급 수술이 취소되었습니다. COVID-19 팬데믹으로 인한 혼란이 최고조에 달했던 첫 12주 동안 전 세계적으로 2,800만 건 이상의 성인 선택적 수술이 취소된 것으로 추산됩니다. 이는 SARS-CoV-2 감염 환자 관리에 필요한 병원 자원을 확보하기 위한 조치였습니다.
또한, 공급망 차질과 개인의 가처분 소득 감소 역시 이러한 카테터 수요 감소에 영향을 미쳤습니다. 그러나 팬데믹이 지속됨에 따라 선택적 수술이 재개되고 공급망 차질이 해소되면 이러한 카테터 시장은 회복될 것으로 예상됩니다.
세그먼트 분석
통증 관리 부문은 예측 기간(2022-2029년) 동안 가장 빠른 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.
통증 관리 부문은 가장 높은 시장 점유율을 차지하고 있습니다. 오피오이드 진통제의 효과적이고 안전한 대안으로, 지속적 카테터 신경 차단술(지속적 말초 신경 차단술)은 만성 통증 관리에 도움을 줍니다. 이 신경 차단술은 부작용이 적은 동시에 고용량의 경구 진통제 복용 필요성을 효과적으로 줄여줍니다. 카테터가 삽입되면 환자는 장기간에 걸쳐 이를 이용하여 통증을 관리할 수 있습니다.
카테터는 통증을 유발하는 말초 신경 근처의 피부 아래에 삽입되는 가늘고 유연한 플라스틱 튜브입니다. 통증 조절을 위해 카테터는 통증 부위에 지속적으로 진통제를 투여합니다.
오용, 의존성 및 과다 복용의 위험이 있는 오피오이드 진통제의 대안으로 지속적 카테터 신경 차단술이 있습니다. 이 신경 차단술은 운동 기능 차단은 최소화하면서 감각 신경 차단을 극대화하는 기술입니다.

지리적 분석
북미 지역은 전 세계 지속적 말초신경 차단 카테터 시장에서 가장 큰 시장 점유율을 차지하고 있습니다.
북미는 지속적 말초신경 차단 카테터 시장을 주도하고 있으며, 예측 기간 동안에도 이러한 추세가 지속될 것으로 예상됩니다. 기술 발전, 무릎 관절 치환술 건수 증가, 그리고 북미 지역 시장 참여 기업들의 신제품 출시 등이 시장 성장을 견인하고 있습니다.
2022년 Cureus 저널에 발표된 논문에 따르면, 무릎 관절 전치환술(TKR)은 미국에서 매년 최대 100만 건이 시행되는 흔한 수술입니다. 2030년에는 연간 350만 건으로 증가할 것으로 예상됩니다. 이 수술은 상당한 수술 후 통증을 유발합니다. 수술 후 통증 완화는 생리적 부작용 외에도 환자의 치료 만족도를 결정하는 중요한 요소입니다. 또한, 급성 통증을 제대로 치료하지 않으면 만성 통증으로 이어질 수 있기 때문에 수술 후 통증 완화는 매우 중요합니다.

경막외 진통의 대안으로 지속적인 주입을 위한 카테터를 이용한 대퇴 신경의 말초 신경 차단술(CPNB)이 있습니다. 무릎 관절 치환술의 증가로 북미 지역의 지속적 말초 신경 차단 카테터 시장 수요가 증가하고 있습니다.
경쟁 환경
지속적 말초 신경 차단 카테터 시장은 국내외 기업들이 경쟁하는 비교적 경쟁적인 시장입니다. 시장 성장에 기여하는 주요 기업으로는 Ambu A/S, Teleflex Incorporated, B. Braun Melsungen AG, Smiths Group plc, Halyard Health, Pajunk GmbH, EPIMED INTERNATIONAL, Ace Medical, Lepu Medical Technology Co.,Ltd 및 Vygon 등이 있습니다. 주요 기업들은 신제품 출시, 인수, 협력 등 다양한 성장 전략을 통해 전 세계 지속적 말초 신경 차단 카테터 시장의 성장에 기여하고 있습니다.

예를 들어,
• 2022년 2월, 내구 의료기기 제조업체와 의료 서비스 제공업체를 위한 외래 환자 진료를 지원하는 선도적인 전국 의료 서비스 제공업체인 InfuSystem Holdings, Inc.는 Solo-Dex, Inc.와 자사의 독자적인 연속 신경 차단 카테터 유통 계약을 체결했습니다.
Teleflex Incorporated
개요:
Teleflex는 사람들의 건강과 삶의 질을 향상시키기 위해 설립된 의료 기술 회사입니다. 이 회사는 혈관 및 중재적 접근, 외과, 마취, 심장 치료, 비뇨기과, 응급 의학 및 호흡기 치료 분야에서 광범위한 솔루션 포트폴리오를 제공합니다.
제품 포트폴리오:
Arrow StimuCath 연속 신경 차단 키트: Arrow 마취과 의사는 자극, 초음파 또는 이 둘의 조합을 사용하여 StimuCath 연속 신경 차단 키트를 말초 신경 차단에 사용합니다. 초음파 보조 치료 중 StimuCath의 독특한 스테인리스 스틸 코일 팁은 카테터 자극을 통해 신경 가까이에 삽입되었는지 확인할 수 있도록 하며 시야를 더욱 확보해 줍니다.

글로벌 지속적 말초신경 차단 카테터 시장 보고서는 약 60개 이상의 시장 데이터 표, 50개 이상의 그림, 그리고 약 200페이지 분량의 자료를 제공합니다.

보고서 요약(영어 원문)

Market Overview
The global Continuous Peripheral Nerve Block Catheters market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029).
A continuous peripheral nerve block catheter is a small tube inserted near a peripheral nerve to deliver anesthesia or pain medication directly to the nerve. This type of catheter allows for continuous medication administration over an extended period rather than receiving a single injection. It is typically used for postoperative pain management in patients who have undergone surgery on a limb or other peripheral body part.
Market Dynamics
Technological advancements drive the global Continuous Peripheral Nerve Block Catheters market growth. Continuous peripheral nerve block catheters are becoming more widely utilized, particularly in hospitals, because catheter placement can be done more precisely and is less expensive than other analgesic delivery techniques.
An increasing benefit of continuous peripheral nerve block catheters drives the market growth
Foot and ankle surgery is often associated with postoperative opioid use, which has been demonstrated to be associated with several postoperative complications. As per the article published in Case Reports in Anesthesiology in 2021, continuous peripheral nerve blocks (CPNB) are a safe and effective method of pain management for outpatient foot and ankle surgery. CPNBs have also been shown to reduce the requirement of rescue opioid use following ambulatory orthopedic surgery compared to single-shot peripheral nerve blocks (PNB). Early work has suggested that continuous peripheral nerve block catheters should be removed after 48 hours due to the increased risk of infection.
CPNBs allow for increased flexibility in the duration and intensity of blocks compared to single-shot PNBs postoperatively. Early studies have shown that the risk of infection increases following 48 hours with an indwelling peripheral nerve block catheter. A recent study reported that the likelihood of infection-free peripheral catheter decreases from 99% on day 4 to 96% on day 7 to 73% on day 15.
Depending on the surgical procedure, peripheral nerve catheters can provide complete analgesia and negate the need for additional pain relief during recovery. This may lead to improved patient satisfaction and reductions in opioid use, hospital length of stay and persistent postoperative pain. There may also be improvements in functional rehabilitation, including earlier mobilization, a greater range of joint motion and better engagement with physiotherapy.
The risk factors associated with continuous peripheral nerve block catheters will hamper the growth of the market
However, there are several potential risks associated with the use of continuous peripheral nerve block catheters. Any invasive procedure carries a risk of infection. The risk is low, but infections can occur at the site where the catheter is inserted or where the anesthesia or pain medication is delivered. The catheter could cause damage to the nerve it is near, which can lead to pain, numbness or weakness in the affected limb. Blood clots can form in the limb where the catheter is inserted, which can be life-threatening if they travel to the lungs. Overdose is a risk with any pain medication, and the continuous administration of medication through a catheter can increase the risk. Some people may have an allergic reaction to the medication being administered through the catheter. The catheter may become dislodged, which can cause pain, bleeding, or decreased effectiveness of the anesthesia or pain medication.
COVID-19 Impact Analysis
The COVID-19 pandemic has particularly impacted the continuous peripheral nerve block catheters market. Due to the pandemic, elective surgeries, which account for a significant portion of the market for these catheters, have been delayed or canceled. This has led to a reduction in demand for these catheters. As per the article published in The Canadian Journal of Anesthesia in 2021, the COVID-19 pandemic caused by the SARS-CoV-2 virus has challenged society and healthcare systems. The early response to the pandemic necessitated canceling many elective and non-urgent surgeries. It is estimated that more than 28 million adult elective surgical procedures were canceled worldwide during the first 12 weeks of peak disruption due to the COVID‐19 pandemic. This response was to conserve hospital resources needed to manage patients with SARS-CoV-2 infection.
Additionally, supply chain disruptions and decreased disposable income among individuals have also contributed to the decrease in demand for these catheters. However, as the pandemic continues, the market for these catheters will likely recover as elective surgeries resume and supply chain disruptions are resolved.
Segment Analysis
The pain management segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)
The pain management segment accounts for the highest market share. As an efficient and secure alternative to opioid painkillers, a continuous catheter nerve block, also known as a continuous peripheral nerve block, aids in the management of chronic pain. The nerve block often has fewer side effects while effectively reducing the requirement for high dosages of oral painkillers. Once the catheter is in place, the patient can utilize it to manage their pain over the long term.
A catheter is a narrow, flexible plastic tube inserted beneath the skin close to the pain-causing peripheral nerve. To assist in controlling the pain, the catheter continuously administers painkillers to the affected portion of the body.
Alternatives to opioid medicines, which carry the danger of misuse, dependence, and potential overdose, include continuous catheter nerve blocks. The nerve block is a technique for maximizing sensory blocking with the least lingering motor blocking.
Geographical Analysis
North America region holds the largest market share of the global continuous peripheral nerve block catheters market
North America dominates the market for continuous peripheral nerve block catheters and is expected to show a similar trend over the forecast period. Technological advancements drive the market, an increasing number of knee replacement surgeries, and product launches by market players in the North American region.
As per the article published in Cureus Journal in 2022, total knee replacement (TKR) is a commonly performed procedure, with up to one million TKRs performed annually in the US. It is expected to increase to 3.5 million per year in 2030. This procedure is associated with significant postoperative pain. Postoperative pain relief is a major determinant of a patient’s satisfaction with treatment in addition to the physiological ill effects. Postoperative pain relief is also important because inadequately treated acute pain may lead to chronic pain.
An alternative to epidural analgesia is peripheral nerve blockade of the femoral nerve using catheters for continuous infiltration, also called continuous perineural blockade (CPNB). The increasing knee replacement procedures lead to increasing demand for continuous peripheral nerve block catheter markets in the North American region.
Competitive Landscape
The continuous peripheral nerve block catheters market is a moderately competitive presence of local and global companies. Some of the key players which are contributing to the growth of the market are Ambu A/S, Teleflex Incorporated, B. Braun Melsungen AG, Smiths Group plc, Halyard Health, Pajunk GmbH, EPIMED INTERNATIONAL, Ace Medical, Lepu Medical Technology Co.,Ltd and Vygon, among others. The major players are adopting several growth strategies, such as Type launches, acquisitions, and collaborations, contributing to the growth of the continuous peripheral nerve block catheters market globally.
For instance,
• In February 2022, InfuSystem Holdings, Inc., a leading national healthcare service provider facilitating outpatient care for durable medical equipment manufacturers and healthcare providers, agreed with Solo-Dex, Inc. for its proprietary continuous nerve block catheter distribution.
Teleflex Incorporated
Overview:
Teleflex is a medical technology company designed to improve the health and quality of people’s lives. The company provides a broad portfolio with solutions in vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care.
Product Portfolio:
Arrow StimuCath Continuous Nerve block kits: Arrow Anesthesiologists who use stimulation, ultrasound, or a combination of both to place StimuCath Continuous Nerve block kits cater to peripheral nerve blocks. During ultrasonography-assisted treatments, StimuCath's distinctive stainless steel coil tip permits catheter stimulation to confirm insertion close to the nerves and offers greater visibility.
The global continuous peripheral nerve block catheters market report would provide access to approximately 60+ market data tables, 50+ figures, and in the range of 200 (approximate) pages.

상세 목차

1. Market Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Number of Geriatric Population
4.1.2. An increasing benefit of continuous peripheral nerve block catheters Restraints:
4.1.2.1. Postoperative Discomfort
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Stimulating Catheter*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2021-2029
7.2.3. Open Tip Catheter Stimulating Catheter
7.2.4. Closed Tip Catheter Stimulating Catheter
7.3. Non-Stimulating Catheter
7.3.1. Open Tip Catheter Non-Stimulating Catheter
7.3.2. Closed Tip Catheter Non-Stimulating Catheter
7.4. Over-The-Needle Catheter
8. By Insertion Technique
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Insertion Technique
8.1.2. Market Attractiveness Index, By Insertion Technique
8.2. Ultrasound*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Nerve Stimulation
8.4. Both
9. By Indication
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
9.1.2. Market Attractiveness Index, By Indication
9.2. Trauma Cases*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Upper Extremity Surgeries
9.4. Lower extremity Surgeries
9.5. Pain Management
9.6. Other Indications
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Ambulatory Surgery Clinics
10.4. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Insertion Technique
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Insertion Technique
11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Insertion Technique
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Insertion Technique
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Insertion Technique
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Type Benchmarking
13. Company Profiles
13.1. Ambu A/S*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Teleflex Incorporated
13.3. B. Braun Melsungen AG
13.4. Smiths Group plc
13.5. Halyard Health
13.6. Pajunk GmbH
13.7. EPIMED INTERNATIONAL
13.8. Vygon
13.9. Ace Medical
13.10. Lepu Medical Technology Co.,Ltd
LIST NOT EXHAUSTIVE
14. Global Continuous Peripheral Nerve Block Catheters Market – DataM
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us

언급된 주요 기업들

Ambu A/S, Teleflex Incorporated, B. Braun Melsungen AG, Smiths Group plc, Halyard Health, Pajunk GmbH, EPIMED INTERNATIONAL, Vygon, Ace Medical, Lepu Medical Technology Co.,Ltd

표 목록 (Tables)

List of Tables

Table 01 Global Continuous Peripheral Nerve Block Catheters Market Value, By Product Type 2023, 2027 & 2031 ($ Million)

Table 02 Global Continuous Peripheral Nerve Block Catheters Market Value, By Insertion Technique, 2023, 2027 & 2031 ($ Million)

Table 03 Global Continuous Peripheral Nerve Block Catheters Market Value, By Indication, 2023, 2027 & 2031 ($ Million)

Table 04 Global Continuous Peripheral Nerve Block Catheters Market Value, By End User, 2023, 2027 & 2031 ($ Million)

Table 05 Global Continuous Peripheral Nerve Block Catheters Market Value, By Region, 2023, 2027 & 2031 ($ Million)

Table 06 Global Continuous Peripheral Nerve Block Catheters Market Value, By Product Type 2023, 2027 & 2031 ($ Million)

Table 07 Global Continuous Peripheral Nerve Block Catheters Market Value, By Product Type, 2022-2031 ($ Million)

Table 08 Global Continuous Peripheral Nerve Block Catheters Market Value, By Insertion Technique, 2023, 2027 & 2031 ($ Million)

Table 09 Global Continuous Peripheral Nerve Block Catheters Market Value, By Insertion Technique, 2022-2031 ($ Million)

Table 10 Global Continuous Peripheral Nerve Block Catheters Market Value, By Indication, 2023, 2027 & 2031 ($ Million)

Table 11 Global Continuous Peripheral Nerve Block Catheters Market Value, By Indication, 2022-2031 ($ Million)

Table 12 Global Continuous Peripheral Nerve Block Catheters Market Value, By End User, 2023, 2027 & 2031 ($ Million)

Table 13 Global Continuous Peripheral Nerve Block Catheters Market Value, By End User, 2022-2031 ($ Million)

Table 14 Global Continuous Peripheral Nerve Block Catheters Market Value, By Region, 2023, 2027 & 2031 ($ Million)

Table 15 Global Continuous Peripheral Nerve Block Catheters Market Value, By Region, 2022-2031 ($ Million)

Table 16 North America Continuous Peripheral Nerve Block Catheters Market Value, By Product Type, 2022-2031 ($ Million)

Table 17 North America Continuous Peripheral Nerve Block Catheters Market Value, By Insertion Technique, 2022-2031 ($ Million)

Table 18 North America Continuous Peripheral Nerve Block Catheters Market Value, By Indication, 2022-2031 ($ Million)

Table 19 North America Continuous Peripheral Nerve Block Catheters Market Value, By End User, 2022-2031 ($ Million)

Table 20 North America Continuous Peripheral Nerve Block Catheters Market Value, By Country, 2022-2031 ($ Million)

Table 21 South America Continuous Peripheral Nerve Block Catheters Market Value, By Product Type, 2022-2031 ($ Million)

Table 22 South America Continuous Peripheral Nerve Block Catheters Market Value, By Insertion Technique, 2022-2031 ($ Million)

Table 23 South America Continuous Peripheral Nerve Block Catheters Market Value, By Indication, 2022-2031 ($ Million)

Table 24 South America Continuous Peripheral Nerve Block Catheters Market Value, By End User, 2022-2031 ($ Million)

Table 25 South America Continuous Peripheral Nerve Block Catheters Market Value, By Country, 2022-2031 ($ Million)

Table 26 Europe Continuous Peripheral Nerve Block Catheters Market Value, By Product Type, 2022-2031 ($ Million)

Table 27 Europe Continuous Peripheral Nerve Block Catheters Market Value, By Insertion Technique, 2022-2031 ($ Million)

Table 28 Europe Continuous Peripheral Nerve Block Catheters Market Value, By Indication, 2022-2031 ($ Million)

Table 29 Europe Continuous Peripheral Nerve Block Catheters Market Value, By End User, 2022-2031 ($ Million)

Table 30 Europe Continuous Peripheral Nerve Block Catheters Market Value, By Country, 2022-2031 ($ Million)

Table 31 Asia-Pacific Continuous Peripheral Nerve Block Catheters Market Value, By Product Type, 2022-2031 ($ Million)

Table 32 Asia-Pacific Continuous Peripheral Nerve Block Catheters Market Value, By Insertion Technique, 2022-2031 ($ Million)

Table 33 Asia-Pacific Continuous Peripheral Nerve Block Catheters Market Value, By Indication, 2022-2031 ($ Million)

Table 34 Asia-Pacific Continuous Peripheral Nerve Block Catheters Market Value, By End User, 2022-2031 ($ Million)

Table 35 Asia-Pacific Continuous Peripheral Nerve Block Catheters Market Value, By Country, 2022-2031 ($ Million)

Table 36 Middle East & Africa Continuous Peripheral Nerve Block Catheters Market Value, By Product Type, 2022-2031 ($ Million)

Table 37 Middle East & Africa Continuous Peripheral Nerve Block Catheters Market Value, By Insertion Technique, 2022-2031 ($ Million)

Table 38 Middle East & Africa Continuous Peripheral Nerve Block Catheters Market Value, By Indication, 2022-2031 ($ Million)

Table 39 Middle East & Africa Continuous Peripheral Nerve Block Catheters Market Value, By End User, 2022-2031 ($ Million)

Table 40 Ambu A/S: Overview

Table 41 Ambu A/S: Product Portfolio

Table 43 Ambu A/S: Key Developments

Table 44 Teleflex Incorporated: Overview

Table 45 Teleflex Incorporated: Product Portfolio

Table 46 Teleflex Incorporated: Key Developments

Table 47 B. Braun Melsungen AG: Overview

Table 48 B. Braun Melsungen AG: Product Portfolio

Table 49 B. Braun Melsungen AG: Key Developments

Table 50 Smiths Group plc: Overview

Table 51 Smiths Group plc: Product Portfolio

Table 52 Smiths Group plc: Key Developments

Table 53 Halyard Health: Overview

Table 54 Halyard Health: Product Portfolio

Table 55 Halyard Health: Key Developments

Table 56 Pajunk GmbH: Overview

Table 57 Pajunk GmbH: Product Portfolio

Table 58 Pajunk GmbH: Key Developments

Table 59 EPIMED INTERNATIONAL, BD, Vygon: Overview

Table 60 EPIMED INTERNATIONAL, BD, Vygon: Product Portfolio

Table 61 EPIMED INTERNATIONAL, BD, Vygon: Key Developments

Table 62 Ace Medical: Overview

Table 63 Ace Medical: Product Portfolio

Table 64 Ace Medical: Key Developments

Table 65 Lepu Medical Technology Co.,Ltd: Overview

Table 66 Lepu Medical Technology Co.,Ltd: Product Portfolio

Table 67 Lepu Medical Technology Co.,Ltd: Key Developments

Table 68 Vygon: Overview

Table 69 Vygon: Product Portfolio

Table 70 Vygon: Key Developments

그림 목록 (Figures)

List of Figures

Figure 01 Global Continuous Peripheral Nerve Block Catheters Market Share, By Product Type 2022 & 2031 (%)

Figure 02 Global Continuous Peripheral Nerve Block Catheters Market Share, By Insertion Technique, 2022 & 2031 (%)

Figure 03 Global Continuous Peripheral Nerve Block Catheters Market Share, By Indication, 2022 & 2031 (%)

Figure 04 Global Continuous Peripheral Nerve Block Catheters Market Share, By End User, 2022 & 2031 (%)

Figure 05 Global Continuous Peripheral Nerve Block Catheters Market Share, By Region, 2022 & 2031 (%)

Figure 06 Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 07 Global Continuous Peripheral Nerve Block Catheters Market Y-o-Y Growth, By Product Type, 2022-2031 (%)

Figure 08 Stimulating Catheter: Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 09 Open Tip Catheter Stimulating Catheter: Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 10 Closed Tip Catheter Stimulating Catheter: Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 11 Non-Stimulating Catheter: Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 12 Open Tip Catheter Non-Stimulating Catheter: Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 13 Closed Tip Catheter Non-Stimulating Catheter: Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 14 Over-The-Needle Catheter: Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 15 Global Continuous Peripheral Nerve Block Catheters Market Y-o-Y Growth, By Insertion Technique, 2022-2031 (%)

Figure 16 Ultrasound: Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 17 Nerve Stimulation: Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 18 Both: Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 19 Global Continuous Peripheral Nerve Block Catheters Market Y-o-Y Growth, By Indication, 2022-2031 (%)

Figure 20 Trauma Cases: Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 21 Upper Extremity Surgeries: Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 22 Lower extremity Surgeries: Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 23 Pain Management: Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 24 Other Indications: Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 25 Global Continuous Peripheral Nerve Block Catheters Market Y-o-Y Growth, By End User, 2022-2031 (%)

Figure 26 Hospitals: Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 27 Ambulatory Surgery Clinics: Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 28 Others: Global Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 29 Global Continuous Peripheral Nerve Block Catheters Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 30 North America Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 31 North America Continuous Peripheral Nerve Block Catheters Market Share, By Product Type, 2022 & 2031 (%)

Figure 32 North America Continuous Peripheral Nerve Block Catheters Market Share, By Insertion Technique, 2022 & 2031 (%)

Figure 33 North America Continuous Peripheral Nerve Block Catheters Market Share, By Indication, 2022 & 2031 (%)

Figure 34 North America Continuous Peripheral Nerve Block Catheters Market Share, By End User, 2022 & 2031 (%)

Figure 35 North America Continuous Peripheral Nerve Block Catheters Market Share, By Country, 2022 & 2031 (%)

Figure 36 South America Continuous Peripheral Nerve Block Catheters Market Share, By Product Type, 2022 & 2031 (%)

Figure 37 South America Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 38 South America Continuous Peripheral Nerve Block Catheters Market Share, By Insertion Technique, 2022 & 2031 (%)

Figure 39 South America Continuous Peripheral Nerve Block Catheters Market Share, By Indication, 2022 & 2031 (%)

Figure 40 South America Continuous Peripheral Nerve Block Catheters Market Share, By End User, 2022 & 2031 (%)

Figure 41 South America Continuous Peripheral Nerve Block Catheters Market Share, By Country, 2022 & 2031 (%)

Figure 42 Europe Continuous Peripheral Nerve Block Catheters Market Share, By Product Type, 2022 & 2031 (%)

Figure 43 Europe Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 44 Europe Continuous Peripheral Nerve Block Catheters Market Share, By Insertion Technique, 2022 & 2031 (%)

Figure 45 Europe Continuous Peripheral Nerve Block Catheters Market Share, By Indication, 2022 & 2031 (%)

Figure 46 Europe Continuous Peripheral Nerve Block Catheters Market Share, By End User, 2022 & 2031 (%)

Figure 47 Europe Continuous Peripheral Nerve Block Catheters Market Share, By Country, 2022 & 2031 (%)

Figure 48 Asia-Pacific Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 49 Asia-Pacific Continuous Peripheral Nerve Block Catheters Market Share, By Product Type, 2022 & 2031 (%)

Figure 50 Asia-Pacific Continuous Peripheral Nerve Block Catheters Market Share, By Insertion Technique, 2022 & 2031 (%)

Figure 51 Asia-Pacific Continuous Peripheral Nerve Block Catheters Market Share, By Indication, 2022 & 2031 (%)

Figure 52 Asia-Pacific Continuous Peripheral Nerve Block Catheters Market Share, By End User, 2022 & 2031 (%)

Figure 53 Asia-Pacific Continuous Peripheral Nerve Block Catheters Market Share, By Country, 2022 & 2031 (%)

Figure 54 Middle East & Africa Continuous Peripheral Nerve Block Catheters Market Share, By Product Type, 2022 & 2031 (%)

Figure 55 Middle East & Africa Continuous Peripheral Nerve Block Catheters Market Value, 2022-2031 ($ Million)

Figure 56 Middle East & Africa Continuous Peripheral Nerve Block Catheters Market Share, By Insertion Technique, 2022 & 2031 (%)

Figure 57 Middle East & Africa Continuous Peripheral Nerve Block Catheters Market Share, By Indication, 2022 & 2031 (%)

Figure 58 Middle East & Africa Continuous Peripheral Nerve Block Catheters Market Share, By End User, 2022 & 2031 (%)

Figure 59 Ambu A/S: Financials

Figure 60 Teleflex Incorporated: Financials

Figure 61 B. Braun Melsungen AG: Financials

Figure 62 Smiths Group plc: Financials

Figure 63 Halyard Health: Financials

Figure 64 Pajunk GmbH: Financials

Figure 65 EPIMED INTERNATIONAL, BD, Vygon: Financials

Figure 66 Ace Medical: Financials

Figure 67 Lepu Medical Technology Co.,Ltd: Financials

Figure 68 Vygon: Financials

글로벌 지속적 말초신경 차단 카테터 시장 – 2023-2030

Global Continuous Peripheral Nerve Block Catheters Market - 2023-2030